Compare · ANPC vs HUM
ANPC vs HUM
Side-by-side comparison of AnPac Bio-Medical Science Co. Ltd. (ANPC) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ANPC and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM carries a market cap of $54.05B.
- HUM has hit the wire 12 times in the past 4 weeks while ANPC has been quiet.
- HUM has more recent analyst coverage (25 ratings vs 0 for ANPC).
- Company
- AnPac Bio-Medical Science Co. Ltd.
- Humana Inc.
- Price
- -
- -
- Market cap
- -
- $54.05B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 0
- 12
- Recent ratings
- 0
- 25
AnPac Bio-Medical Science Co. Ltd.
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China. It offers cancer differentiation analysis devices and physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest ANPC
- AnPac Bio-Medical Science Co. Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- AnPac Bio-Medical Science Co. Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- AnPac Bio-Medical Science Co. Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits
- AnPac Bio-Medical Science Co. Ltd. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form 3 filed by new insider Liang Zhijun
- SEC Form 3 filed by new insider Zhao Zhigang
- SEC Form 3 filed by new insider Li Xiaoyu
- SEC Form 3 filed by new insider Pu Tianruo
- SEC Form 3 filed by new insider Tian Honggang
- New insider Xu Haohan claimed ownership of 69,774,679 units of Class A Ordinary Shares (SEC Form 3) (Amendment)
Latest HUM
- Humana upgraded by RBC Capital Mkts with a new price target
- Director Frederick Wayne A.I. sold $193,853 worth of Humana Common (440 units at $440.57), closing all direct ownership in the company (SEC Form 4)
- President, Enterprise Growth Dintenfass David gifted 230 units of Humana Common, decreasing direct ownership by 0.91% to 25,177 units (SEC Form 4)
- Chief Legal Officer Ventura Joseph C sold $2,384,013 worth of Humana Common (5,495 units at $433.85) and gifted 437 units of Humana Common, decreasing direct ownership by 22% to 21,473 units (SEC Form 4)
- New oncology model from Humana, Evolent and American Oncology Network eliminates prior authorization burden
- Humana Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment
- Humana Commences Offers to Purchase for Cash Certain of its Outstanding Debt Securities
- SEC Form 10-Q filed by Humana Inc.
- Humana Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits